Cannabinoids: a real prospect for pain relief?
paper
Cited
Public
Unavailable
- Authors
- Iversen, Leslie; Chapman, Victoria
- Year
- 2002
- Journal
- Current opinion in pharmacology
- PMID
- 11786308
- DOI
- 10.1016/s1471-4892(01)00120-5
Research on the therapeutic potential of cannabinoids has grown dramatically over the past few years. Recent advances include evidence that cannabinoid agonists are antihyperalgesic and antiallodynic in models of neuropathic pain. Development of novel cannabinoid agonists and cannabinoid preparations that are antinociceptive has important implications for the therapeutic use of this class of drugs.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality. | Carrascosa AJ et al. | β | 2024 | β |
| Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders. | Kumar U | β | 2024 | β |
| Interaction of the synthetic cannabinoid WIN55212 with tramadol on nociceptive thresholds and core body temperature in a chemotherapy-induced peripheral neuropathy pain model. | Haddad M et al. | β | 2023 | β |
| Pharmacokinetics, efficacy, and safety of cannabidiol in dogs: an update of current knowledge. | Di Salvo A et al. | β | 2023 | β |
| Potent dual MAGL/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain. | Della Pietra A et al. | β | 2023 | β |
| Down-regulation of NR2B receptors contributes to the analgesic and antianxiety effects of enriched environment mediated by endocannabinoid system in the inflammatory pain mice. | Jiang S et al. | β | 2022 | β |
| Future Treatment of Neuropathic Pain in Spinal Cord Injury: The Challenges of Nanomedicine, Supplements or Opportunities? | Forte G et al. | β | 2022 | β |
| Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain. | Della Pietra A et al. | β | 2022 | β |
| Maladaptive reorganization following SCI: The role of body representation and multisensory integration. | Vastano R et al. | β | 2022 | β |
| Antinociception mechanisms of action of cannabinoid-based medicine: an overview for anesthesiologists and pain physicians. | Narouze S | β | 2021 | β |
| Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine. | Della Pietra A et al. | β | 2021 | β |
| Effect of Postoperative Analgesic Exposure to the Cannabinoid Receptor Agonist WIN55 on Osteogenic Differentiation and Spinal Fusion in Rats. | Yun C et al. | β | 2021 | β |
| Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management. | Shah SA et al. | β | 2021 | β |
| Analgesic Effects and Impairment in Locomotor Activity Induced by Cannabinoid/Opioid Combinations in Rat Models of Chronic Pain. | Alsalem M et al. | β | 2020 | β |
| An evaluation of the anti-hyperalgesic effects of cannabidiolic acid-methyl ester in a preclinical model of peripheral neuropathic pain. | Zhu YF et al. | β | 2020 | β |
| Efficacy of Dronabinol for Acute Pain Management in Adults with Traumatic Injury: Study Protocol of A Randomized Controlled Trial. | Swartwood C et al. | β | 2020 | β |
| Matched pilot study examining cannabis-based dronabinol for acute pain following traumatic injury. | Schneider-Smith E et al. | β | 2020 | β |
| Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies. | Reddy V et al. | β | 2020 | β |
| Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases. | Darkovska-Serafimovska M et al. | β | 2018 | β |
| Acute Thymic Involution and Mechanisms for Recovery. | Ansari AR et al. | β | 2017 | β |
| Age-dependent plasticity in endocannabinoid modulation of pain processing through postnatal development. | Kwok CH et al. | β | 2017 | β |
| Cannabinoid CB<sub>2</sub> Agonist GW405833 Suppresses Inflammatory and Neuropathic Pain through a CB<sub>1</sub> Mechanism that is Independent of CB<sub>2</sub> Receptors in Mice. | Li AL et al. | β | 2017 | β |
| Cannabinoid CB<sub>1</sub> and CB<sub>2</sub> Receptor Signaling and Bias. | Ibsen MS et al. | β | 2017 | β |
| Do Cannabinoids Confer Neuroprotection Against Epilepsy? An Overview. | Capasso A | β | 2017 | β |
| Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease. | Kokona D et al. | β | 2016 | β |
| The effect of spinally administered WIN 55,212-2, a cannabinoid agonist, on thermal pain sensitivity in diabetic rats. | Jahanabadi S et al. | β | 2016 | β |
| Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor. | Khajehali E et al. | β | 2015 | β |
| Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis. | Carey CE et al. | β | 2015 | β |
| Cannabinoids for neuropathic pain. | Fine PG et al. | β | 2014 | β |
| Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats. | Toniolo EF et al. | β | 2014 | β |
| Amygdala activity contributes to the dissociative effect of cannabis on pain perception. | Lee MC et al. | β | 2013 | β |
| The endocannabinoid system, cannabinoids, and pain. | Fine PG et al. | β | 2013 | β |
| Acute reduction of anandamide-hydrolase (FAAH) activity is coupled with a reduction of nociceptive pathways facilitation in medication-overuse headache subjects after withdrawal treatment. | Perrotta A et al. | β | 2012 | β |
| Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids. | Luchicchi A et al. | β | 2012 | β |
| Dynamic changes to the endocannabinoid system in models of chronic pain. | Rani Sagar D et al. | β | 2012 | β |
| Interactions between Ξ(9)-tetrahydrocannabinol and heroin: self-administration in rhesus monkeys. | Li JX et al. | β | 2012 | β |
| Actions of ethanolamine on cultured sensory neurones from neonatal rats. | Khairy H et al. | β | 2010 | β |
| Effects of COX-2 inhibition on spinal nociception: the role of endocannabinoids. | Staniaszek LE et al. | β | 2010 | β |
| In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB(2) receptor inverse agonists. | Cascio MG et al. | β | 2010 | β |
| The Role of Cannabinoid Receptors in the Descending Modulation of Pain. | Palazzo E et al. | β | 2010 | β |
| Agmatine enhances cannabinoid action in the hot-plate assay of thermal nociception. | Aggarwal S et al. | β | 2009 | β |
| Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis. | Conte A et al. | β | 2009 | β |
| Characterization of human hepatic and extrahepatic UDP-glucuronosyltransferase enzymes involved in the metabolism of classic cannabinoids. | Mazur A et al. | β | 2009 | β |
| Dynamic regulation of the endocannabinoid system: implications for analgesia. | Sagar DR et al. | β | 2009 | β |
| Novel endogenous peptide agonists of cannabinoid receptors. | Gomes I et al. | β | 2009 | β |
| Pyridine-3-carboxamides as novel CB(2) agonists for analgesia. | Mitchell WL et al. | β | 2009 | β |
| Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons. | Liu Q et al. | β | 2009 | β |
| Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain. | Hama A et al. | β | 2009 | β |
| Activation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs. | Giannini L et al. | β | 2008 | β |
| Analgesic and antihyperalgesic effects of nabilone on experimental heat pain. | Redmond WJ et al. | β | 2008 | β |
| Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI. | Chin CL et al. | β | 2008 | β |
| Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain. | Cristino L et al. | β | 2008 | β |
| Modulation of sensory neuron potassium conductances by anandamide indicates roles for metabolites. | Evans RM et al. | β | 2008 | β |
| The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats. | de Novellis V et al. | β | 2008 | β |
| Therapeutic potential of CB2 targeting in multiple sclerosis. | Docagne F et al. | β | 2008 | β |
| Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors. | Maione S et al. | β | 2007 | β |
| Hemopressin is an inverse agonist of CB1 cannabinoid receptors. | Heimann AS et al. | β | 2007 | β |
| Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration. | Dziadulewicz EK et al. | β | 2007 | β |
| The acetaminophen-derived bioactive N-acylphenolamine AM404 inhibits NFAT by targeting nuclear regulatory events. | Caballero FJ et al. | β | 2007 | β |
| The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes. | Kracke GR et al. | β | 2007 | β |
| Why do cannabinoids not show consistent effects as analgetic drugs in multiple sclerosis? | Lienau FS et al. | β | 2007 | β |
| A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientists. | Di Marzo V | β | 2006 | β |
| [A case of a second cancer of metachronous multiple primary non-small cell lung cancer successfully treated with TS-1 and CDDP chemotherapy]. | Tsunezuka Y et al. | β | 2006 | β |
| Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors. | Maione S et al. | β | 2006 | β |
| First "hybrid" ligands of vanilloid TRPV1 and cannabinoid CB2 receptors and non-polyunsaturated fatty acid-derived CB2-selective ligands. | Appendino G et al. | β | 2006 | β |
| In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands. | Cascio MG et al. | β | 2006 | β |
| Iodinated N-acylvanillamines: potential "multiple-target" anti-inflammatory agents acting via the inhibition of t-cell activation and antagonism at vanilloid TRPV1 channels. | MΓ‘rquez N et al. | β | 2006 | β |
| Metabotropic glutamate and cannabinoid receptor crosstalk in periaqueductal grey pain processing. | Palazzos E et al. | β | 2006 | β |
| Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system. | Palazzo E et al. | β | 2006 | β |
| Plant, synthetic, and endogenous cannabinoids in medicine. | Di Marzo V et al. | β | 2006 | β |
| Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes. | Manzanares J et al. | β | 2006 | β |
| Allosteric modulation of the cannabinoid CB1 receptor. | Price MR et al. | β | 2005 | β |
| Cannabis and endocannabinoid modulators: Therapeutic promises and challenges. | Grant I et al. | β | 2005 | β |
| Cannabis use in HIV for pain and other medical symptoms. | Woolridge E et al. | β | 2005 | β |
| Effects of repeated administration with CP-55,940, a cannabinoid CB1 receptor agonist on the metabolism of the hepatic heme. | Fontanellas A et al. | β | 2005 | β |
| Lipid mediators regulating pain sensitivity. | Malan TP et al. | β | 2005 | β |
| Oleylethanolamide impairs glucose tolerance and inhibits insulin-stimulated glucose uptake in rat adipocytes through p38 and JNK MAPK pathways. | GonzΓ‘lez-Yanes C et al. | β | 2005 | β |
| Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons. | Wotherspoon G et al. | β | 2005 | β |
| Purification and mass spectroscopic analysis of human CB1 cannabinoid receptor functionally expressed using the baculovirus system. | Xu W et al. | β | 2005 | β |
| The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors. | Shoemaker JL et al. | β | 2005 | β |
| Differential modulation of withdrawal reflexes by a cannabinoid in the rabbit. | Jenkins S et al. | β | 2004 | β |
| Metabolomic differentiation of Cannabis sativa cultivars using 1H NMR spectroscopy and principal component analysis. | Choi YH et al. | β | 2004 | β |
| Multiple actions of anandamide on neonatal rat cultured sensory neurones. | Evans RM et al. | β | 2004 | β |
| NMR assignments of the major cannabinoids and cannabiflavonoids isolated from flowers of Cannabis sativa. | Choi YH et al. | β | 2004 | β |
| Purification and mass spectroscopic analysis of human CB2 cannabinoid receptor expressed in the baculovirus system. | Filppula S et al. | β | 2004 | β |
| Putative therapeutic targets in the treatment of visceral hyperalgesia. | Collins S | β | 2004 | β |
| Role of endocannabinoid system in mental diseases. | Manzanares J et al. | β | 2004 | β |
| The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of Guinea pig mast cells: involvement of nitric oxide and eicosanoids. | Vannacci A et al. | β | 2004 | β |
| The endocannabinoid system and its therapeutic exploitation. | Di Marzo V et al. | β | 2004 | β |
| Activation of peripheral cannabinoid CB1 receptors inhibits mechanically evoked responses of spinal neurons in noninflamed rats and rats with hindpaw inflammation. | Kelly S et al. | β | 2003 | β |
| Anandamide and vanilloid TRPV1 receptors. | Ross RA | β | 2003 | β |
| Behavioural and gene transcription alterations induced by spontaneous cannabinoid withdrawal in mice. | Oliva JM et al. | β | 2003 | β |
| Cannabinoids: potential anticancer agents. | GuzmΓ‘n M | β | 2003 | β |
| Cannabis and the brain. | Iversen L | β | 2003 | β |
| Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats. | Sokal DM et al. | β | 2003 | β |
| Modulation of anxiety through blockade of anandamide hydrolysis. | Kathuria S et al. | β | 2003 | β |
| Role of endogenous cannabinoids in synaptic signaling. | Freund TF et al. | β | 2003 | β |
| The molecular logic of endocannabinoid signalling. | Piomelli D | β | 2003 | β |
| Brain monoglyceride lipase participating in endocannabinoid inactivation. | Dinh TP et al. | β | 2002 | β |